Navigation Links
Omthera Stockholders Approve Acquisition by AstraZeneca
Date:7/16/2013

PRINCETON, N.J., July 16, 2013 /PRNewswire/ -- The stockholders of Omthera Pharmaceuticals, Inc. (NASDAQ: OMTH) (the "Company") voted today at a special meeting of stockholders to adopt the previously announced merger agreement providing for the acquisition of the Company by an affiliate of AstraZeneca PLC.  The votes cast by the Company's stockholders in favor of the proposal to adopt the merger agreement represented approximately 88.3 percent of the Company's issued and outstanding common stock entitled to vote as of June 13, 2013, the record date for the special meeting.

(Logo: http://photos.prnewswire.com/prnh/20130528/NY21129LOGO-a)

The receipt of the approval of the Company's stockholders of the proposal to adopt the merger agreement satisfies one of the conditions to consummation of the proposed merger.  The consummation of the merger remains subject to certain other closing conditions set forth in the merger agreement.

About Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for dyslipidemia and the treatment of cardiovascular disease. Epanova™, currently the Company's sole product candidate, is a late-stage, novel, omega-3 free fatty acid composition that meaningfully reduces triglycerides, improves other key lipid parameters and is expected to increase patient convenience with 2-gram once-a-day dosing with or without meals. Epanova™ is a coated soft gelatin capsule containing a complex mixture of polyunsaturated free fatty acids derived from fish oils, including multiple long-chain omega-3 and omega-6 fatty acids, with EPA, DHA, and docosapentaenoic acid being the most abundant forms of omega-3 fatty acids.
'/>"/>

SOURCE Omthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omthera Announces Waiver of Lock-Up Restriction
2. Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders
3. Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm
4. Omthera Pharmaceuticals Announces First Quarter 2013 Financial Results
5. Covington Advises Omthera Pharmaceuticals on Merger with AstraZeneca
6. Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering
7. Omthera Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
8. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
9. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... , April 27, 2015 ... completed filing of a Pre-Marketing Notification Application (510k) with ... BRH-A2 Wound Management System. BRH Medical expects feedback from ... the US market with BRH-A2 following FDA pre-market clearance. ... Motti Oderberg , CEO for BRH Medical, ...
(Date:4/27/2015)... , April 27, 2015 TWi Pharmaceuticals, ... into a Settlement Agreement with Takeda Pharmaceutical Company ... Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, ... litigation related to TWi,s generic dexlansoprazole delayed release ... 60 mg dosage strengths. An Abbreviated New Drug Application ...
(Date:4/24/2015)... NASHUA, New Hampshire , und ... 2015 (Stand Nr. 4410) iCAD, ... führender Anbieter von moderner Bildanalyse, Lösungen für ... Behandlung von Krebserkrankungen, hat heute die sofortige ... ® Electronic Brachytherapy (eBx ® ) ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2TWi Announces Settlement with Takeda on Dexilant(R) Litigation 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6
... YORK, Jan. 20, 2011 Reportlinker.com announces that ... its catalogue: Hospital Radiography & ... This is the most comprehensive ... radiology modality types (General Radiology, Mammography, R&F, Angiography, ...
... 2011 CyberKnife Center of Miami ( www.cyberknifemiami.com ... FACRO, FASTRO, announces a presentation regarding CyberKnife Treatment ... Association of Neurosurgeon,s Annual Meeting, on January 28, ... http://photos.prnewswire.com/prnh/20110120/FL32893 ) The presentation is ...
Cached Medicine Technology:Reportlinker Adds Hospital Radiography & Fluoroscopy Census 2CyberKnife Center of Miami to Present at 38th Annual Caribbean Association of Neurosurgeon's Conference 2
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... Cannabix Technologies Inc. (CSE: BLO) (OTC ... Iannapollo has become an Advisor to Cannabix Technologies, developer ... and workplace testing. Mr. Iannapollo is an expert on ... experience in the oil and gas industry, working for ... employer, and DOT compliance policies and strategies. He also ...
(Date:4/27/2015)... The global coagulation analyzers market ... in developed countries; however, it is expected to ... China, India and Brazil in the next five ... driven by factors such as increasing adoption of ... high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation ...
(Date:4/27/2015)... 2015 The Global Pharmaceutical Packaging Market ... CAGR of 5.9% during the period 2015 – 2019. ... materials healthcare packaging market, mainly due to their cost ... market is extremely fragmented with the presence of ... of the market with the rest being occupied by ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 On the ... the dramatic nighttime skyline of beautiful Los Angeles, CA, ... host, star of “The Real Housewives of Orange County” ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... center for substance abuse founded by Wickstrom, Rossi felt ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4Health News:Per Wickstrom Shares His Vision of Choices Recovery with Reality TV Star Gretchen Christine Rossi 2
... are worried about whether sporadic outbreaks of bird flu could ... impact of the H5N1 bird flu infection has been minimal ... a million lives, worldwide. ,The bird flu virus ... it has not inherited genetic changes that would enable human ...
... the cards that will be a landmark on the EM ... project which will come up// in two phases that will ... cancer patients. Bangalore and Ahmedabad will follow suit with ... Foundation chairman, had a meeting with the chief minister to ...
... of the leading insomnia drug companies. But at present it is ... this October. There's a range of insomnia drugs on the market, ... for some of the people who depend on Ambien for a ... supply for the French pharmaceutical company of late. A string of ...
... division, Loyola University Health System, Maywood, Ill has noted that ... NCAA Tournament // on the television screens turns even the ... is important to prevent injuring oneself even as you enjoy ... especially painful and require months of rehabilitation, so it’s best ...
... claimed two more lives, as informed by regulators who issued ... combination from the market. The drug combination, also called Mifeprex ... in any of those cases//. ,The Food and Drug ... infection previously implicated in four deaths of women who had ...
... Health Service in Wales will end this financial year ?71m ... that confirmed by the National Health Service in Wales will ... also been confirmed by the assembly government. It is a ... budget for the Welsh NHS is around ?4.9bn. ...
Cached Medicine News:Health News:Ambien and the Other Insomnia Drugs 2
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
... VICTOR2 V measures ... polarization, luminescence, time-resolved ... absorbance. A red-sensitive ... assay. All technologies ...
... is the modular VICTOR2 ... high density TR-fluorometry, stacker ... The extra high density ... excitation beam for TRF ...
Flexible and sensitive fluorescence/luminescence microplate reader for endpoint and kinetic...
Medicine Products: